News

Göttingen researchers succeeded in measuring the release of the neurotransmitter dopamine from nerve cells with unprecedented accuracy. This enables scientists to study the mechanisms that control dopamine signaling in more detail and to better elucidate the development of related diseases. Link to the MPI-NAT press release (in German)

The German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) is funding research into personalised treatment options for Noonan syndrome in the Stem Cell Unit at the University Medical Center Göttingen (UMG) with 467,580 euros. The team led by MBExC member Dr Lukas Cyganek will conduct research for three years on the topic

The academy honors the director at the Max-Planck-Institute of Multidisciplinary Sciences and MBExC member with the admission as a Foreign Member for her innovative research on the structure and function of ribosomes – the protein factories of cells. Link to the press release of the MPI-NAT (in German)

Researchers at the University Medical Center Göttingen and the Institute for Bioengineering of Catalonia in Spain have succeeded for the first time worldwide, in stimulating hearing in vivo by light without the need for genetic manipulation. This new light-controlled drug, capable of triggering the neural pathways involved in hearing, can

The Peter and Traudl Engelhorn Foundation awards MBExC member Prof. Dr. Hauke Hillen for his work on the molecular mechanisms of gene activation of viruses and mitochondria. The Peter and Traudl Engelhorn Research Award is endowed with 10,000 euros. Link to the press release of the UMG (in German)

The German Research Foundation (DFG) will in future fund a new Research Training Group (RTG) in biological physics at Göttingen University. A total of 25 PhD students and one data scientist will thus receive financial support for their structured training in an interdisciplinary field of physics. The Research Training Group

Experts from the University Medical Center Göttingen and the Baylor College of Medicine in Houston, Texas, summarize 20 years of Junctophilin research, new molecular analyses, and the role of Junctophilins in the development of human diseases in a comprehensive in-depth review article. Published with Spotlight Cover in the renowned journal

Certain metabolic products are suitable as indication for Parkinson’s disease. Researchers and MBExC members at the Max Planck Institute (MPI) for Multidisciplinary Sciences, the University Medical Center Göttingen (UMG), and the German Center for Neurodegenerative Diseases (DZNE) have used this insight in a first step to develop a new diagnostics

MBExC member Claus Ropers, professor at the Physics department at Göttingen University and director of the Department of Ultrafast Dynamics at the Max Planck Institute for Multidisciplinary Sciences, receives the prestigious Advanced Grant from the European Commission for his innovative research project. With the ERC funding, Ropers’ team wants to

MBExC speaker Tobias Moser, director of the Institute for Auditory Neuroscience at the University Medical Center Göttingen, received an ERC Advanced Grant. The European Research Council (ERC) supports his research project „Solving the dynamic range problem of hearing: deciphering and harnessing cochlear mechanisms of sound intensity coding (DynaHear)“ over five